Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Barclays analyst Matt Miksic initiates coverage on Alcon (NYSE:ALC) with a Equal-Weight rating and announces Price Target of...
BTIG analyst Ryan Zimmerman maintains Alcon (NYSE:ALC) with a Buy and lowers the price target from $92 to $91.
Raises Concerns About Whether the Board Fulfilled Its Fiduciary Duty of Care in Doubling Down on Its Commitment to Proposed Tra...
Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or th...
STAAR Continues to Significantly Underestimate the Strength of the Business and Future Prospects and Misrepresent Its Performan...
Contends There Is No Business Justification for the Board's Decision to Sell the Company for $28 Per Share Now After Reject...
Broadwood Believes the Transaction Comes at the Wrong Time, After the Wrong Process, and at the Wrong PriceFor the Reasons Desc...
Broadwood Believes the Transaction Comes at the Wrong Time, After the Wrong Process, and at the Wrong PriceFor the Reasons Desc...
